Immune checkpoint-mediated psoriasis: A multicenter European study of 115 patients from the European Network for Cutaneous Adverse Event to Oncologic Drugs (ENCADO) group

Vasiliki Nikolaou, V. Sibaud, Davide Fattore, Pietro Sollena, Ariadna Ortiz‐Brugués, Damien Giacchero, Maria Concetta Romano, Julia Riganti, Konstantinos Lallas, Ketty Peris, Dimitra Voudouri, Aimilios Lallas, Gabriella Fabbrocini, Elizabeth Lazaridou, Cristina Carrera, Maria Carmela Annunziata, Ernesto Rossi, Angela Patrì, Dimitrios Rigopoulos, Alexander Stratigos, Zoé Apalla